Willie A. Deese - 23 Jun 2022 Form 4 Insider Report for G1 Therapeutics, Inc.

Role: Director
Signature: /s/ James Stillman Hanson, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 23 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 24 Jun 2022, 16:51:19 UTC
Previous filing: 25 May 2022
Next filing: 06 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GTHX	Common Stock	Award	$0	+10,000	+228%	$0.000000	14,389	23 Jun 2022	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GTHX	Stock Options (Right to Buy)	Award	$0	+30,000		$0.000000	30,000	23 Jun 2022	Common Stock	30,000	$5.30	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director.
F2	Each RSU represents a contingent right to receive one share of Issuer common stock
F3	Represents 4,389 shares of common stock and 10,000 restricted stock units
F4	The shares underlying this option will vest in their entirety twelve months after June 23, 2022, subject to the Reporting Person's continued service as a director.